Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-12-01T01:28:17.128Z Has data issue: false hasContentIssue false
  • English
  • Français

The Rapidly Growing Mycobacteria— Mycobacterium fortuitum and Mycobacterium chelonei

Published online by Cambridge University Press:  02 January 2015

Timothy H. Brown
Timothy H. Brown*
Affiliation:
Veterans Administration Medical Center, Nashville, Tennessee
*
Fort Hamilton Hughes, Memorial Hospital Center, 630 Eaton Avenue, Hamilton, OH 45013
Get access Rights & Permissions [Opens in a new window]

Extract

Recent clinical experience has added Mycobacterium fortuitum and Mycobacterium chelonei to the expanding list of nosocomial pathogens. These rapidly growing mycobacteria were first isolated 80 years ago from frogs (M. fortuitum) and sea turtles (M. chelonei). Obtained occasionally from human sources as early as 1904, they were generally regarded as commensals in man. Friedmann was so convinced of the non-pathogenicity of M. chelonei that he introduced the “turtle vaccine” as a means of preventing and treating tuberculosis. Contemporary medical literature firmly establishes these organisms as human pathogens with particular importance in nosocomial infections.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 6 , Issue 7 , July 1985 , pp. 283 - 288
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1985

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Hand, WL, Sanford, JP: Mycobacterium fortuitum—A human pathogen. Ann Intern Med 1970;73:97 1-977.Google Scholar
2.Kuster, E: Uber kaltblutertuberkulose. Muenchener Medizinische Wochenschrift 1905; 55:57–59.Google Scholar
3.Friedman, FF: Spontane lungentiiberkulose bei Schildkroten und die Stellung des Tuberkelbazillus in system. Zeitschrift fur Tuberkulose 1930a;4:439.Google Scholar
4.Ophuls, W: Chronic subcutaneous abscesses in man containing acid-proof bacilli in pure culture. Journal of Medical Research 1904;11:439.Google Scholar
5.Report: Friedmann's turtle vaccine. Tubercle 1919;1:412.Google Scholar
6.Fowler, WC: A preliminary report on the treatment of tuberculosis with the turtle vaccine. Tubercle 1930;12:12.Google Scholar
7.Da Costa Cruz, J: Mycobacterium fortuitum, un novo bacilo acido resistente patogenico par o homen. Acta Medica Rio de Janiero 1938; 1:297–301.Google Scholar
8.Moore, M, Frerichs, JB: An unusual acid-fast infection of the knee with subcutaneous abscess-like lesions of the gluteal region. J Invest Dermatol 1953;20:133.Google Scholar
9.Stanford, JL, Pattyn, SR, Portaeis, F, et al: Studies on Mycobacterium chehnei. J Med Microbiol 1972; 22:50–51.Google Scholar
10.Runyon, EH: Conservation of the specific epithet fortuitum in the name of the organism known as Mycobacterium fortuitum de Da Costa Cruz. International journal of Systematic Bacteriology 1972; 22:50–51.Google Scholar
11.Band, JD, Ward, JI, Fraser, DW, et al: Peritonitis due to a Mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis. J Infect Dis 1982; 145:9–17.CrossRefGoogle ScholarPubMed
12.Nontuberculous mycobacterial infection in hemodialysis patients. Louisiana 1982. MMWR 1983; 32:244–246.Google Scholar
13.Hoffman, PC, Fraser, DW, Robicsek, F, et alTwo outbreaks of sternal wound infection due to organisms of the Mycobacterium fortuitum complex. J Infect Dis 1981; 143:533–542.CrossRefGoogle ScholarPubMed
14.Kuritsky, JN, Bullen, MC, Broome, CV, et al: Sternal wound infection and endocarditis clue to organisms of the Mycobacterium fortuitum complex. Ann Intern Med 1983; 98:938–939.Google Scholar
15.Clegg, HW, Foster, MT, Sanders, WE, et al: Infection duc to organisms of the Mycobacterium fortuitum complex after augmentation mammoplasly: Clinical and epidemiologic features. J Infect Dis 1983; 147:427–433.Google Scholar
16.Pottage, JC Jr, Harris, AA, Trenholme, GM, et al: Disseminated Mycobacterium chelonei infection: A report of two cases. Am Rev Respir Dis 1982; 126:720–722.Google ScholarPubMed
17.Wolinsky, E: State of the Art: Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 1979; 119:107–159.Google Scholar
18.Righter, J, Hart, GD, Howes, M: Mycobacterium chelonei: Report of a case of septicemia and review of the literature. Diagnostic. Microbiology and Infectious Diseases 1983; 1:323–329.Google Scholar
19.Wallace, RJ Jr, Swenson, JM, Silcox, VA, et al: Spectrum of disease due to rapidly-growing mycobacteria. Rev Infect Dis 1983; 5:657–679.Google Scholar
20.Runyon, EH: Anonymous mycobacteria in pulmonary disease. Med Clin North Am 1959; 43:273–290.CrossRefGoogle ScholarPubMed
21.Tsukamura, M: Differentiation of mycobacteria by picric acid tolerance. Am Rev Respir Dis 1965; 92:491–492.Google ScholarPubMed
22.Tsukamura, M, Tsukamura, S: Differentiation of mycobacteria by susceptibility to nitrate and propylene glvcol. Am Rev Respir Dis 1968;98:505–506.Google Scholar
23.Kubica, CP. Rigdon, AL: The arylsulfatase activity of acid-fast bacilli. III. Preliminary investigation of rapidly growing acid-fast bacilli. Am Rev Respir Dis 1961; 83:737–740.Google Scholar
24.Jones, WD Jr, Kubica, GP: The use of MacConkey's agar for differential typing of Mycobacterium fortuitum. Am J Med Technol 1964; 30:187–190.Google ScholarPubMed
25.Tsukamura, M: Differentiation of mycobacteria by susceptibility to hydroxylaminc and 8-azaguanine. J Bacterial 1965; 90:556–557.CrossRefGoogle ScholarPubMed
26.Hawkins, JE, McClean, VR: Comparative studies of cycloserine inhibition of mycobacteria. Am Rev Respir Dis 1966; 93:594–602.Google ScholarPubMed
27.Silcox, VA, Good, RC, Floyd, MM: Identification of clinically significant Mycobacterium fortuitum complex isolates. J Clin Microbiol 1981; 14:686–691.Google Scholar
28.Jenkins, PA, Marks, J, Schacfer, WB: Lipid chromatography and seroaggltitination in the classification of rapidly growing mycobacteria. Am Rev Respir Dis 1971; 103:179–187.Google ScholarPubMed
29.Haas, H, Michel, J, Sacks, T: Identification of Mycobacterium fortuitum, Mycobacterium abscessus, and Mycobacterium borstelense by Polyacrylamide gel electrophoresis of their cell proteins. International Journal of Systematic Bacteriology 1974; 24:366.Google Scholar
30.Grange, JM: A fluorigenic substrate for the rapid differentiation of Mycobacterium fortuitum from Mycobacterium chelonei on the basis of heat stable esterase activity. Tubercle 1977; 58:147–150.CrossRefGoogle ScholarPubMed
31.Casal, MJ, Rodriguez, FC: Simple, new test for rapid differentiation of the Mycobacterium fortuitum complex. Clin Microbiol 1981; 13:989–990.Google Scholar
32.Morgan, MA, Horstmeier, CD, De Young, DR. et al: Comparison of a radiometric method (BACTEC) and commercial culture media lor recovery of mycobacteria from smear-negative specimens. J Clin Microbiol 1983; 18:384–388.Google Scholar
33.Pierce, PF, DcYoung, DR, Roberts, GD: Mycobacteria and the new blood culture systems. Ann Intern Med 1983; 99:786–789.CrossRefGoogle ScholarPubMed
34.Fojtasek, MF, Kelly, MT: Isolation of Mycobacterium chelonei with the lysis ccntrifugation blood culture technique. J Clin Microbiol 1982; 16:403–405.Google Scholar
35.Wolinsky, E, Rynearson, TK: Mycobacteria in soil and their relation to disease-associated strains. Am Rev Respir Dis 1968; 97:1032–1037.Google Scholar
36.Goslee, S, Wolinsky, E: Water as a source of potentially pathogenic mycobacteria. Am Rev Respir Dis 1976; 113:287–292.Google ScholarPubMed
37.Dawson, DJ: Potential pathogens among strains of mycobacteria isolated from house dust. Med J Aust 1971; 711:679–681.CrossRefGoogle Scholar
38.Gremillion, DH, Mursch, SB, Lerner, CJ: Injection site abscesses caused by Mycobacterium chelonei. Infect Control 1983; 4:25–28.Google Scholar
39.Foz, A, Roy, C, Jurado, J, et al: Mycobacterium chelonei iatrogenic infections. J Clin Microbiol 1978; 7:319–332.Google Scholar
40.Azadian, BS, Beck, A, Curtis, JR. et al: Disseminated infection with Mycobacterium chelonei in a haemodialysis patient. Tubercle 1981; 62:281–284.Google Scholar
41.Bolan, G, Reingold, AL, Carson, L, et al: Mycobacterium chelonei infections in a hemodialysis center. Louisiana, abstracted. Program and abstracts of the 13th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington. DC: American Society for Microbiology, 1983.Google Scholar
42.Good, RC, Snider, DE: Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis 1982; 146:829–833.Google Scholar
43.Sjogren, I: Nontuberculous mycobacteria in Sweden: A brief summary. Rev Infect Dis 1981;3:1084.Google Scholar
44.Szabo', I, Sarkozi, K: Mycobacterium chelonei endemy after heart surgery with fatal consequences. Am Rev Respir Dis 1980;121:607.Google Scholar
45.Sriyabhaya, N, Wongwatana, S: Pulmonary infection caused by atypical mycobacteria: A report of 24 cases from Thailand. Rev Infect Dis 1981; 3:1085–1089.Google Scholar
46.Grange, JM: Mycobacterium chelonei. Tubercle 1981; 62:272–276.Google Scholar
47.Kushner, DS, McMillen, S, Scnderi, M: Atypical acid-fast bacilli. II. Mycobacterium fortuitum: Bacteriologic characteristics and pathogenicity for laboratory animals. Am Rev Respir Dis 1957:76:108.Google Scholar
48.Saito, H. Tasaka, H: Comparison of the pathogenicity lor mice of Mycobacterium fortuitum and Mycobacterium abscessus. J Bacterial 1969;99:851.Google Scholar
49.Canetti, G, Froman, S, Grosset, J, et al: Mycobacteria: Laboratory methods for testing drug sensitivity and resistance. Bull WHO 1963; 29:565–578.Google Scholar
50.Washington, JA II, Sutter, VL: Dilution susceptibility test: Agarand macrobroth dilution procedures. In Lennette, EH. Balows, A. Hauser, WJ Jr, Truant, JP (eds): Manual of Clinical Microbiology, ed 3: Washington, DC, American Society for Microbiology. 1980, pp 453–458.Google Scholar
51.Wallace, RJ Jr, Dalovisio, JR. Pankey, GA: Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents. Antimicrob Agents Chemother 1979; 16:611–614.Google Scholar
52.Dalovisio, JR, Pankey, GA: In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin. J Infect Dis 1978; 137:318–321.Google Scholar
53.Swenson, JM, Thornsberry, C, Silcox, VA: Rapidly growing mycobacteria: Testing of susceptibility to 34 antimicrobial agents by broth microdilution. Antimicrob Agents Chemother 1982; 22:186–192.Google Scholar
54.Stone, MS, Wallace, RJ Jr, Swenson, JM. et al: Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics. Antimicrob Agents Chemother 1983; 24:486–493.CrossRefGoogle ScholarPubMed
55.Yates, MD, Collins, CH: Sensitivity of opportunist mycobacteria lo rifampicin and ethambutol. Tubercle 1981:62:117–121.Google Scholar
56.Swenson, JM, Silcox, V. Wallace, RJ. et al: Antimicrobial susceptibility of 5 subspecies of rapidly growing mycobacteria. Abstracted. Program and abstracts 13th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society lor Microbiology, 1983.Google Scholar
57.Garcia-Rodriguez, JA, Martin-Lucngo, F: Activity of amikacin, erythromycin, and doxycycline against Mycobacterium chelonei and Mycobacterium fortuitum. Tubercle 1978; 59:277–280.CrossRefGoogle ScholarPubMed
58.Haas, H, Michel, J. Sacks, TG: In vitro susceptibility of mycobacteria species other than Mycobacterium tuberculosis to amikacin, cephalosporins, and cefoxitin. Chemotherapy 1982; 28:1–5.Google Scholar
59.Gynamon, MH, Palmer, GS: In vitro susceptibility of Mycobacterium fortuitum to amoxicillin or cephalolhin in combination with clavulanic acid. Antimicrob Agents Chemother 1983; 23:935–937.Google Scholar
60.Molavi, A, Weinstein, L: In vitro activity of erythromycin against atypical mycobacteria. J Infect Dis 1971; 123:216–219.Google Scholar
61.Gynamon, MH, Patapow, A: In vitro susceptibility of Mycobacterium fortuitum to cefoxitin. Antimicrob Agents Chemother 1981: 19:205–207.Google Scholar
62.Casal, M, Rodriguez, F: In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to cefoxitin. Tubercle 1982; 63:125–127.Google Scholar
63.Tsukamura, M: In vitro antimycobacterial activity of minocycline. Tubercle 1980; 61:37–38.Google Scholar
64.Wallace, RJ Jr, Jones, JB, Wiss, K: Sulfonamide activity against Mycobacterium fortuitum and Mycobacterium chelonei. Rev Infect Dis 1981; 3:898–904.Google Scholar
65.Cynamon, MH, Palmer, GS: In vitro susceptibility of Mycobacterium fortuitum to N-formimidoyl thienamycin and several cephamycins. Antimicrob Agents Chemother 1982; 22:1079–1081.Google Scholar
66.Wallace, RJ Jr, Wiss, K, Bushby, MB, et al: In vitro activity of trimethoprim and sulfamethoxazole against nontuberculous mycobacteria. Rev Infect Dis 1982; 4:326–331.Google Scholar
67.Wallace, RJ Jr, Hull, S, Bobey, DC, et al: Mechanism of acquired aminoglycoside resistance in Mycobacterium fortuitum and Mycobacterium chelonei. Abstracted. Program and abstracts 13th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1983.Google Scholar
68.Neitch, SM, Sydnor, JB, Schleupner, CJ: Mycobacterium fortuitum as a cause of mastoiditis and wound infection. Arch Otolaryngol 1982; 108:11–14.CrossRefGoogle ScholarPubMed
69.Meisler, DM, Friedlaencler, MH, Okumoto, M: Mycobacterium chelonei keratitis. Am J Ophthalmol 1982; 94:398–401.Google Scholar
70.Rogers, JH, Raff, MJ, Rumage, WT, et al: Mycobacterium fortuitum abscess related to surgery, malignancy, and a tight girdle. South Med J 1974; 67:397–398.CrossRefGoogle Scholar
71.Fenske, NA, Millns, JL: Resistant cutaneous infection caused by Mycobacterium chelonei. Arch Dermatol 1981; 117:151–153.Google Scholar
72.Jackson, PG, Keen, H, Noble, CJ, et al: Infection abscesses due to Mycobacterium chelonei occurring in a diabetic patient. Tubercle 1981; 62:277–279.Google Scholar
73.Irwin, RS, Pratter, MR, Corwin, RW, et al: Pulmonary infection with Mycobacterium chelonei: Successful treatment with one drug based on disk diffusion susceptibility data. J Infect Dis 1982;145:772.CrossRefGoogle ScholarPubMed
74.Sopko, JA, Fieselman, J, Kasik, JE: Pulmonary disease due to Mycobacterium chelonei subspecies abscessus: A report of four cases. Tubercle 1980; 61:165–169.Google Scholar
75.Speert, DP, Munson, D, Mitchell, C, et al: Mycobacterium chelonei septicemia in a premature infant. J Pediatr 1980; 96:681–683.Google Scholar
76.Katz, MA, Hull, AR: Probable Mycobacterium fortuitum septicemia: Complication of home dialysis. Lancet 1971;1:499.Google Scholar
77.Tice, AD, Solomon, RJ: Disseminated Mycobacterium chelonei infection: Response to sulfonamides. Am Rev Respir Dis 1979; 120:197–201.Google Scholar
78.Graybill, JR, Silva, J Jr, Fraser, DW, et al: Disseminated mycobacteriosis due to Mycobacterium abscessus in two recipients of renal homografts. Am Rev Respir Dis 1974; 109:4–10.Google Scholar
79.Carson, LA, Petersen, NJ, Favero, MS, et al: Growth characteristics of atypical mycobacteria in water and their comparative resistance to disinfectants. Appl Environ Microbiol 1978; 36:839–846.CrossRefGoogle ScholarPubMed
80.Tyras, DH, Kaiser, GC, Barner, HB, et al: Atypical mycobacteria and the xenograft valve. J Thorac Cardiovasc Surg 1978; 75:331–337.Google Scholar
81.Nelson, KE, Larson, PE, Schraufnagel, DE, et al: Transmission of tuberculosis by flexible fiberbronchoscopes. Am Rev Respir Dis 1983; 127:97–100.Google Scholar
82.Berkelman, RL, Holland, BS, Anderson, PL: Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J Clin Microbiol 1982; 15:635–639.Google Scholar
83.Hayes, PS, McGiboney, DL, Band, JD, et al: Resistance of Mycobacterium chelonei-like organisms to formaldehyde. Appl Environ Microbiol 1982; 43:722–724.Google Scholar
84.Carson, LA, Bolan, G, Petersen, NJ, et al: Antimicrobial and formaldehyde resistance patterns of nontuberculous mycobacteria associated with reprocessed hemodialyzers. Abstracted. Program and abstracts 13th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1983.Google Scholar
85.Coates, D, Death, JE: Use of buffered hypochlorite solution for disinfection of fiberscopes. J Clin Microbiol 1982; 35:296–303.Google Scholar
86.Kubin, M, Sedlackova, J, Vacek, K: Ionizing radiation in the disinfection of water contaminated with potentially pathogenic mycobacteria. J Hyg Epidemiol Microbiol Immunol 1982; 26:31–36.Google Scholar
87.Garner, JS, Simmons, BP: Guidelines for isolation precautions in hospitals. Centers for Disease Control, Atlanta, GA. In Infect Control 1983; 4:245–325.Google Scholar
88.Maki, DG, Alvarado, CJ, Hassemer, CA, et al: Relation of the inanimate hospital environment to endemic nosocomial infection. N Engl J Med 1982; 307:1562–1566.Google Scholar